HopeStage
Back to all studies
CompletedNCT04098302

Dutasteride to Reduce Heavy Drinking

About this titleRead the official source — NCT04098302
Medication studyAges 35–70United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 35 years to 70 years.

Listed locations
FarmingtonSee all locations and recruitment
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: October 15, 2019
Recruitment status
Completed
Enrollment listed in the registry
180
Sponsor
UConn Health
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 35 Years to 70 Years
Official registry ID
NCT04098302
Official title
Show the full official title

Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of Efficacy

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Farmington

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is UConn Health.

Did this study involve medication?

Yes. The study involved medication, including Dutasteride Capsules and Placebo Capsules.

Who was this study for?

Listed age limits: 35 years to 70 years.

Want to explore more studies?

Explore studies